Thursday, March 11, 2021 5:06:00 PM
I agree with those who see COVI-STIX and COVI-MSC as EUA candidates and possible revenue earners reasonably soon. But we should recall that there are 6 more potential EUA candidates lined up behind them. That's a lot of potential revenue and partnerships!
But any time Sorrento needs cash they can sell their shares in IBRX for $300+ million and/or their shares in Celularity for $400+ million. And most observers agree that PSS will be handing over some $1.2 Billion in a few months.
And next year there will be billions in revenue from SP-102, RTX and possibly Abivirtinib in cancer and cytokine storm.
Do I worry that Sorrento needs cash? NO.
Do I expect Sorrento will receive some some unsolicited buyout offers? YES.
"The refusal of the real is the number one dogma of our time" Rene Girard
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM